Amryt Pharma plc

Amryt Pharma plcverified

AMYT

Price:

$14.7

Market Cap:

$0

Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-07-08

Stock Exchange

NASDAQ

Ticker

AMYT

The PE Ratio as of July 2024 (TTM) for Amryt Pharma plc (AMYT) is 39.73

According to Amryt Pharma plc’s latest financial reports and current stock price. The company's current PE Ratio is 39.73. This represents a change of -848.40% compared to the average of -5.31 of the last 4 quarters.

Amryt Pharma plc (AMYT) Historical PE Ratio (quarterly & annually)

How has AMYT PE Ratio performed in the past?

The mean historical PE Ratio of Amryt Pharma plc over the last ten years is -15.92. The current 39.73 PE Ratio has changed -25056.29% with respect to the historical average. Over the past ten years (40 quarters), AMYT's PE Ratio was at its highest in in the December 2021 quarter at 7.70. The PE Ratio was at its lowest in in the June 2021 quarter at -16.00.

Quarterly (TTM)
Annual

Average

-15.92

Median

-4.93

Minimum

-73.00

Maximum

-1.08

Amryt Pharma plc (AMYT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Amryt Pharma plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 478.73%

Maximum Annual PE Ratio = -1.08

Minimum Annual Increase = -90.32%

Minimum Annual PE Ratio = -73.00

Quarterly (TTM)
Annual
YearPE RatioChange
2021-28.04478.73%
2020-4.84163.17%
2019-1.84-14.53%
2018-2.1599.73%
2017-1.08-78.47%
2016-5.01133.62%
2015-2.14-90.32%
2014-22.1316.74%
2013-18.96-74.03%
2012-73.00293.06%

Amryt Pharma plc (AMYT) Average PE Ratio

How has AMYT PE Ratio performed in the past?

The current PE Ratio of Amryt Pharma plc (AMYT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-11.57

5-year avg

-7.59

10-year avg

-15.92

Amryt Pharma plc (AMYT) PE Ratio vs. Peers

How is AMYT’s PE Ratio compared to its peers?

Amryt Pharma plc’s PE Ratio is greater than Universe Pharmaceuticals INC (-2.18), greater than Regencell Bioscience Holdings Limited (-9.45), greater than Indigenous Bloom Hemp Corp. (-0.06), greater than Eagle Pharmaceuticals, Inc. (7.04), greater than Sangui Biotech International, Inc. (-7.32), greater than Qilian International Holding Group Limited (-28.44), greater than IM Cannabis Corp. (-2.20), less than GelStat Corporation (0), greater than Pacira BioSciences, Inc. (-3.52), greater than Collegium Pharmaceutical, Inc. (12.78), greater than Prestige Consumer Healthcare Inc. (11.21), greater than Incannex Healthcare Limited (16.96), greater than Phibro Animal Health Corporation (-1.81), less than Shuttle Pharmaceuticals Holdings, Inc. (57.30), greater than Mallinckrodt plc (-1.04), greater than Organogenesis Holdings Inc. (-0.00), greater than Lucy Scientific Discovery Inc. (25.92), greater than Alimera Sciences, Inc. (-0.72), greater than null (-14.14),

Build a custom stock screener for Amryt Pharma plc (AMYT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amryt Pharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amryt Pharma plc (AMYT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amryt Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Amryt Pharma plc's PE Ratio?

How is the PE Ratio calculated for Amryt Pharma plc (AMYT)?

What is the highest PE Ratio for Amryt Pharma plc (AMYT)?

What is the 3-year average PE Ratio for Amryt Pharma plc (AMYT)?

What is the 5-year average PE Ratio for Amryt Pharma plc (AMYT)?

How does the current PE Ratio for Amryt Pharma plc (AMYT) compare to its historical average?